Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages.

Chua ACY, Ong JJY, Malleret B, Suwanarusk R, Kosaisavee V, Zeeman AM, Cooper CA, Tan KSW, Zhang R, Tan BH, Abas SN, Yip A, Elliot A, Joyner CJ, Cho JS, Breyer K, Baran S, Lange A, Maher SP, Nosten F, Bodenreider C, Yeung BKS, Mazier D, Galinski MR, Dereuddre-Bosquet N, Le Grand R, Kocken CHM, Rénia L, Kyle DE, Diagana TT, Snounou G, Russell B, Bifani P.

Nat Commun. 2019 Aug 12;10(1):3635. doi: 10.1038/s41467-019-11332-4.

2.

In silico epitope mapping and experimental evaluation of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) as a malaria vaccine candidate.

Cravo P, Machado RB, Leite JA, Leda T, Suwanarusk R, Bittencourt N, Albrecht L, Judice C, Lopes SCP, Lacerda MVG, Ferreira MU, Soares IS, Goh YS, Bargieri DY, Nosten F, Russell B, Rénia L, Costa FTM.

Malar J. 2018 Jan 10;17(1):20. doi: 10.1186/s12936-017-2144-x.

3.

In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.

Basilico N, Parapini S, Sparatore A, Romeo S, Misiano P, Vivas L, Yardley V, Croft SL, Habluetzel A, Lucantoni L, Renia L, Russell B, Suwanarusk R, Nosten F, Dondio G, Bigogno C, Jabes D, Taramelli D.

Molecules. 2017 Dec 1;22(12). pii: E2102. doi: 10.3390/molecules22122102.

4.

Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation.

Chu TTT, Sinha A, Malleret B, Suwanarusk R, Park JE, Naidu R, Das R, Dutta B, Ong ST, Verma NK, Chan JK, Nosten F, Rénia L, Sze SK, Russell B, Chandramohanadas R.

Br J Haematol. 2018 Jan;180(1):118-133. doi: 10.1111/bjh.14976. Epub 2017 Nov 2.

PMID:
29094334
5.

Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi.

Kosaisavee V, Suwanarusk R, Chua ACY, Kyle DE, Malleret B, Zhang R, Imwong M, Imerbsin R, Ubalee R, Sámano-Sánchez H, Yeung BKS, Ong JJY, Lombardini E, Nosten F, Tan KSW, Bifani P, Snounou G, Rénia L, Russell B.

Blood. 2017 Sep 14;130(11):1357-1363. doi: 10.1182/blood-2017-02-764787. Epub 2017 Jul 11.

6.

Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.

Bancone G, Malleret B, Suwanarusk R, Chowwiwat N, Chu CS, McGready R, Rénia L, Nosten F, Russell B.

J Infect Dis. 2017 Jul 15;216(2):263-266. doi: 10.1093/infdis/jix278.

7.

Rheopathologic Consequence of Plasmodium vivax Rosette Formation.

Zhang R, Lee WC, Lau YL, Albrecht L, Lopes SC, Costa FT, Suwanarusk R, Nosten F, Cooke BM, Rénia L, Russell B.

PLoS Negl Trop Dis. 2016 Aug 10;10(8):e0004912. doi: 10.1371/journal.pntd.0004912. eCollection 2016 Aug.

8.

Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand.

Auburn S, Serre D, Pearson RD, Amato R, Sriprawat K, To S, Handayuni I, Suwanarusk R, Russell B, Drury E, Stalker J, Miotto O, Kwiatkowski DP, Nosten F, Price RN.

J Infect Dis. 2016 Oct 15;214(8):1235-42. doi: 10.1093/infdis/jiw323. Epub 2016 Jul 24.

9.

Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax.

de Cassan SC, Shakri AR, Llewellyn D, Elias SC, Cho JS, Goodman AL, Jin J, Douglas AD, Suwanarusk R, Nosten FH, Rénia L, Russell B, Chitnis CE, Draper SJ.

Front Immunol. 2015 Jul 8;6:348. doi: 10.3389/fimmu.2015.00348. eCollection 2015.

10.

A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609.

Zhang R, Suwanarusk R, Malleret B, Cooke BM, Nosten F, Lau YL, Dao M, Lim CT, Renia L, Tan KS, Russell B.

J Infect Dis. 2016 Jan 1;213(1):100-4. doi: 10.1093/infdis/jiv358. Epub 2015 Jul 1.

11.

An amidation/cyclization approach to the synthesis of N-hydroxyquinolinones and their biological evaluation as potential anti-plasmodial, anti-bacterial, and iron(II)-chelating agents.

Teng Y, Suwanarusk R, Ngai MH, Srinivasan R, Ong AS, Ho B, Rénia L, Chai CL.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):607-10. doi: 10.1016/j.bmcl.2014.12.014. Epub 2014 Dec 13.

PMID:
25544370
12.

Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.

Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jiménez-Díaz MB, Angulo-Barturen I, Santos Martínez M, Ferrer S, Sanz LM, Gamo FJ, Wittlin S, Duffy S, Avery VM, Ruecker A, Delves MJ, Sinden RE, Fuchter MJ, Scherf A.

Antimicrob Agents Chemother. 2015 Feb;59(2):950-9. doi: 10.1128/AAC.04419-14. Epub 2014 Nov 24.

13.

Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes.

Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, Cho JS, Koh EG, Chu CS, Pukrittayakamee S, Ng ML, Ginhoux F, Ng LG, Lim CT, Nosten F, Snounou G, Rénia L, Russell B.

Blood. 2015 Feb 19;125(8):1314-24. doi: 10.1182/blood-2014-08-596015. Epub 2014 Nov 20.

14.

Characterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assay.

Loh CC, Suwanarusk R, Lee YQ, Chan KW, Choy KY, Rénia L, Russell B, Lear MJ, Nosten FH, Tan KS, Chow LM.

PLoS One. 2014 Oct 24;9(10):e110800. doi: 10.1371/journal.pone.0110800. eCollection 2014.

15.

Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.

Suwanarusk R, Russell B, Ong A, Sriprawat K, Chu CS, PyaePhyo A, Malleret B, Nosten F, Renia L.

J Antimicrob Chemother. 2015 Jan;70(1):124-9. doi: 10.1093/jac/dku326. Epub 2014 Aug 21.

16.

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.

Kuhen KL, Chatterjee AK, Rottmann M, Gagaring K, Borboa R, Buenviaje J, Chen Z, Francek C, Wu T, Nagle A, Barnes SW, Plouffe D, Lee MC, Fidock DA, Graumans W, van de Vegte-Bolmer M, van Gemert GJ, Wirjanata G, Sebayang B, Marfurt J, Russell B, Suwanarusk R, Price RN, Nosten F, Tungtaeng A, Gettayacamin M, Sattabongkot J, Taylor J, Walker JR, Tully D, Patra KP, Flannery EL, Vinetz JM, Renia L, Sauerwein RW, Winzeler EA, Glynne RJ, Diagana TT.

Antimicrob Agents Chemother. 2014 Sep;58(9):5060-7. doi: 10.1128/AAC.02727-13. Epub 2014 Jun 9.

17.

Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes.

Lee WC, Malleret B, Lau YL, Mauduit M, Fong MY, Cho JS, Suwanarusk R, Zhang R, Albrecht L, Costa FT, Preiser P, McGready R, Renia L, Nosten F, Russell B.

Blood. 2014 May 1;123(18):e100-9. doi: 10.1182/blood-2013-12-541698. Epub 2014 Mar 20. Erratum in: Blood. 2015 Dec 17;126(25):2765.

18.

Targeting Plasmodium PI(4)K to eliminate malaria.

McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ, Zeeman AM, Dechering KJ, Kumar TS, Henrich PP, Gagaring K, Ibanez M, Kato N, Kuhen KL, Fischli C, Nagle A, Rottmann M, Plouffe DM, Bursulaya B, Meister S, Rameh L, Trappe J, Haasen D, Timmerman M, Sauerwein RW, Suwanarusk R, Russell B, Renia L, Nosten F, Tully DC, Kocken CH, Glynne RJ, Bodenreider C, Fidock DA, Diagana TT, Winzeler EA.

Nature. 2013 Dec 12;504(7479):248-253. doi: 10.1038/nature12782. Epub 2013 Nov 27.

19.

Significant biochemical, biophysical and metabolic diversity in circulating human cord blood reticulocytes.

Malleret B, Xu F, Mohandas N, Suwanarusk R, Chu C, Leite JA, Low K, Turner C, Sriprawat K, Zhang R, Bertrand O, Colin Y, Costa FT, Ong CN, Ng ML, Lim CT, Nosten F, Rénia L, Russell B.

PLoS One. 2013 Oct 8;8(10):e76062. doi: 10.1371/journal.pone.0076062. eCollection 2013.

20.

A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus.

Koh S, Shimasaki N, Suwanarusk R, Ho ZZ, Chia A, Banu N, Howland SW, Ong AS, Gehring AJ, Stauss H, Renia L, Sällberg M, Campana D, Bertoletti A.

Mol Ther Nucleic Acids. 2013 Aug 13;2:e114. doi: 10.1038/mtna.2013.43.

21.

Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity.

Russell B, Malleret B, Suwanarusk R, Anthony C, Kanlaya S, Lau YL, Woodrow CJ, Nosten F, Renia L.

Antimicrob Agents Chemother. 2013 Oct;57(10):5170-4. doi: 10.1128/AAC.00682-13. Epub 2013 Jul 22.

22.

Giemsa-stained wet mount based method for reticulocyte quantification: a viable alternative in resource limited or malaria endemic settings.

Lee WC, Russell B, Lau YL, Fong MY, Chu C, Sriprawat K, Suwanarusk R, Nosten F, Renia L.

PLoS One. 2013;8(4):e60303. doi: 10.1371/journal.pone.0060303. Epub 2013 Apr 2.

23.

Human ex vivo studies on asexual Plasmodium vivax: the best way forward.

Russell B, Suwanarusk R, Malleret B, Costa FT, Snounou G, Kevin Baird J, Nosten F, Rénia L.

Int J Parasitol. 2012 Nov;42(12):1063-70. doi: 10.1016/j.ijpara.2012.08.010. Epub 2012 Sep 29. Review.

24.

Plasmodium vivax adherence to placental glycosaminoglycans.

Chotivanich K, Udomsangpetch R, Suwanarusk R, Pukrittayakamee S, Wilairatana P, Beeson JG, Day NP, White NJ.

PLoS One. 2012;7(4):e34509. doi: 10.1371/journal.pone.0034509. Epub 2012 Apr 17.

25.

Cerebral malaria: mysteries at the blood-brain barrier.

Rénia L, Howland SW, Claser C, Charlotte Gruner A, Suwanarusk R, Hui Teo T, Russell B, Ng LF.

Virulence. 2012 Mar-Apr;3(2):193-201. doi: 10.4161/viru.19013. Epub 2012 Mar 1. Review.

26.

Genetic diversity in new members of the reticulocyte binding protein family in Thai Plasmodium vivax isolates.

Kosaisavee V, Lek-Uthai U, Suwanarusk R, Grüner AC, Russell B, Nosten F, Rénia L, Snounou G.

PLoS One. 2012;7(3):e32105. doi: 10.1371/journal.pone.0032105. Epub 2012 Mar 5. Erratum in: PLoS One. 2012;7(6). doi:10.1371/annotation/4e852b7d-735e-436f-bc66-3c31706b5f26.

27.

A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development.

Malleret B, Claser C, Ong AS, Suwanarusk R, Sriprawat K, Howland SW, Russell B, Nosten F, Rénia L.

Sci Rep. 2011;1:118. doi: 10.1038/srep00118. Epub 2011 Oct 14.

28.

Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture.

Borlon C, Russell B, Sriprawat K, Suwanarusk R, Erhart A, Renia L, Nosten F, D'Alessandro U.

Int J Parasitol. 2012 Feb;42(2):155-60. doi: 10.1016/j.ijpara.2011.10.011. Epub 2011 Dec 27.

29.

Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship.

Prajapati SK, Joshi H, Shalini S, Patarroyo MA, Suwanarusk R, Kumar A, Sharma SK, Eapen A, Dev V, Bhatt RM, Valecha N, Nosten F, Rizvi MA, Dash AP.

Malar J. 2011 Dec 19;10:374. doi: 10.1186/1475-2875-10-374.

30.

Considerations on the use of nucleic acid-based amplification for malaria parasite detection.

Proux S, Suwanarusk R, Barends M, Zwang J, Price RN, Leimanis M, Kiricharoen L, Laochan N, Russell B, Nosten F, Snounou G.

Malar J. 2011 Oct 28;10:323. doi: 10.1186/1475-2875-10-323.

31.

A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax.

Russell B, Suwanarusk R, Borlon C, Costa FT, Chu CS, Rijken MJ, Sriprawat K, Warter L, Koh EG, Malleret B, Colin Y, Bertrand O, Adams JH, D'Alessandro U, Snounou G, Nosten F, Rénia L.

Blood. 2011 Sep 29;118(13):e74-81. doi: 10.1182/blood-2011-04-348748. Epub 2011 Jul 18.

32.

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.

Imwong M, Russell B, Suwanarusk R, Nzila A, Leimanis ML, Sriprawat K, Kaewpongsri S, Phyo AP, Snounou G, Nosten F, Renia L.

J Infect Dis. 2011 Jan 15;203(2):207-10. doi: 10.1093/infdis/jiq024. Epub 2010 Dec 9.

33.

The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.

Kaewpongsri S, Sriprawat K, Suwanarusk R, Kyle DE, Lek-Uthai U, Leimanis M, Lwin KM, Phyo AP, Zwang J, Russell B, Nosten F, Renia L.

Antimicrob Agents Chemother. 2011 Mar;55(3):1300-4. doi: 10.1128/AAC.01103-10. Epub 2010 Dec 28.

34.

Spiroindolones, a potent compound class for the treatment of malaria.

Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT.

Science. 2010 Sep 3;329(5996):1175-80. doi: 10.1126/science.1193225.

35.

On the cytoadhesion of Plasmodium vivax-infected erythrocytes.

Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, Mamoni R, Leite JA, Rodrigues MM, Soares IS, Oliveira TR, Wunderlich G, Lacerda MV, del Portillo HA, Araújo MO, Russell B, Suwanarusk R, Snounou G, Rénia L, Costa FT.

J Infect Dis. 2010 Aug 15;202(4):638-47. doi: 10.1086/654815.

PMID:
20617923
36.

Plasmodium vivax susceptibility to ferroquine.

Leimanis ML, Jaidee A, Sriprawat K, Kaewpongsri S, Suwanarusk R, Barends M, Phyo AP, Russell B, Renia L, Nosten F.

Antimicrob Agents Chemother. 2010 May;54(5):2228-30. doi: 10.1128/AAC.01572-09. Epub 2010 Mar 22.

37.

Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood.

Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, Phyo AP, Snounou G, Russell B, Renia L, Nosten F.

Malar J. 2009 Jun 2;8:115. doi: 10.1186/1475-2875-8-115.

38.

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.

Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, Prasetyorini B, Kenangalem E, Piera KA, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN.

J Infect Dis. 2008 Nov 15;198(10):1558-64. doi: 10.1086/592451.

39.

Plasmodium vivax trophozoites insensitive to chloroquine.

Sharrock WW, Suwanarusk R, Lek-Uthai U, Edstein MD, Kosaisavee V, Travers T, Jaidee A, Sriprawat K, Price RN, Nosten F, Russell B.

Malar J. 2008 May 27;7:94. doi: 10.1186/1475-2875-7-94.

40.

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

Lek-Uthai U, Suwanarusk R, Ruengweerayut R, Skinner-Adams TS, Nosten F, Gardiner DL, Boonma P, Piera KA, Andrews KT, Machunter B, McCarthy JS, Anstey NM, Price RN, Russell B.

Antimicrob Agents Chemother. 2008 Jul;52(7):2435-41. doi: 10.1128/AAC.00169-08. Epub 2008 Apr 28.

41.

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.

Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, Brockman A, Prayoga P, Sugiarto P, Cheng Q, Tjitra E, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2008 Mar;52(3):1040-5. doi: 10.1128/AAC.01334-07. Epub 2008 Jan 7.

42.

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.

Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN.

PLoS One. 2007 Oct 31;2(10):e1089.

43.

Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum.

Boonma P, Christensen PR, Suwanarusk R, Price RN, Russell B, Lek-Uthai U.

Malar J. 2007 Sep 15;6:124.

44.

Plasmodium vivax genetic diversity: microsatellite length matters.

Russell B, Suwanarusk R, Lek-Uthai U.

Trends Parasitol. 2006 Sep;22(9):399-401. Epub 2006 Jul 11. Review.

PMID:
16837246
45.

Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.

Kosaisavee V, Suwanarusk R, Nosten F, Kyle DE, Barrends M, Jones J, Price R, Russell B, Lek-Uthai U.

Exp Parasitol. 2006 Sep;114(1):34-9. Epub 2006 Mar 20.

PMID:
16545375
46.

The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax.

Suwanarusk R, Cooke BM, Dondorp AM, Silamut K, Sattabongkot J, White NJ, Udomsangpetch R.

J Infect Dis. 2004 Jan 15;189(2):190-4. Epub 2004 Jan 5.

PMID:
14722882

Supplemental Content

Loading ...
Support Center